Alivexis
Minato
About Alivexis
Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus is comprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $53.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2022)
- Website: alivexis.com
- Phone: +81 3-6868-4547
Industries & Categories
Biotechnology, Clinical Trials, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/alivexis-40825 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.